576 related articles for article (PubMed ID: 30676843)
1. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
Hotta C; Ogawa T; Shirasawa H
Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
[TBL] [Abstract][Full Text] [Related]
2. Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV).
Okada K; Miyazaki C; Kino Y; Ozaki T; Hirose M; Ueda K
J Infect Dis; 2013 Jul; 208(2):275-83. PubMed ID: 23568174
[TBL] [Abstract][Full Text] [Related]
3. Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany.
Eggers M; Terletskaia-Ladwig E; Rabenau HF; Doerr HW; Diedrich S; Enders G; Enders M
BMC Infect Dis; 2010 Dec; 10():347. PubMed ID: 21143885
[TBL] [Abstract][Full Text] [Related]
4. Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan.
Satoh H; Tanaka-Taya K; Shimizu H; Goto A; Tanaka S; Nakano T; Hotta C; Okazaki T; Itamochi M; Ito M; Okamoto-Nakagawa R; Yamashita Y; Arai S; Okuno H; Morino S; Oishi K
Vaccine; 2019 Mar; 37(14):1964-1971. PubMed ID: 30827736
[TBL] [Abstract][Full Text] [Related]
5. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
[TBL] [Abstract][Full Text] [Related]
6. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label, randomised, controlled trial.
He H; Wang Y; Deng X; Yue C; Tang X; Li Y; Liu Y; Yin Z; Zhang G; Chen Z; Xie S; Wen N; An Z; Chen Z; Wang H
Lancet Infect Dis; 2020 Sep; 20(9):1071-1079. PubMed ID: 32442523
[TBL] [Abstract][Full Text] [Related]
8. [Study of immunogenicity after primary vaccination by different sequential program of inactivated poliovirus vaccine and oral poliovirus vaccine].
Lu L; Li XM; Liu DL; Zhang HR; Zhang ZJ; Wang HH; Liu F; Ning ZQ; Zhang LW; Chu P; Xie YT; Xu Y; Li J; Pang XH; Deng Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):510-3. PubMed ID: 22943896
[TBL] [Abstract][Full Text] [Related]
9. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
Crawt L; Atkinson E; Tedcastle A; Pegg E; ; Minor P; Cooper G; Rigsby P; Martin J
J Infect Dis; 2020 Feb; 221(4):544-552. PubMed ID: 30788503
[TBL] [Abstract][Full Text] [Related]
10. Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses.
Sun M; Li C; Xu W; Liao G; Li R; Zhou J; Li Y; Cai W; Yan D; Che Y; Ying Z; Wang J; Yang H; Ma Y; Ma L; Ji G; Shi L; Jiang S; Li Q
Clin Infect Dis; 2017 May; 64(10):1317-1325. PubMed ID: 28419204
[TBL] [Abstract][Full Text] [Related]
11. Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.
Hendry AJ; Beard FH; Dey A; Quinn H; Hueston L; Dwyer DE; McIntyre PB
Vaccine; 2020 Mar; 38(11):2572-2577. PubMed ID: 32037225
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity study to investigate the interchangeability among three different types of polio vaccine: A cohort study in Japan.
Ohfuji S; Ito K; Ishibashi M; Shindo S; Takasaki Y; Yokoyama T; Yokoyama T; Yamashita Y; Shibao K; Nakano T; Tsuru T; Irie S; Hirota Y
Medicine (Baltimore); 2017 Jun; 96(23):e7073. PubMed ID: 28591046
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
[TBL] [Abstract][Full Text] [Related]
14. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China.
Li RC; Li CG; Wang HB; Luo HM; Li YP; Wang JF; Ying ZF; Yu WZ; Shu JD; Wen N; Vidor E
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):287-96. PubMed ID: 26407255
[TBL] [Abstract][Full Text] [Related]
16. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.
Bandyopadhyay AS; Asturias EJ; O'Ryan M; Oberste MS; Weldon W; Clemens R; Rüttimann R; Modlin JF; Gast C
Vaccine; 2017 Dec; 35(52):7283-7291. PubMed ID: 29150209
[TBL] [Abstract][Full Text] [Related]
17. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
18. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
Xiao Y; Daniell H
Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147
[TBL] [Abstract][Full Text] [Related]
19. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing anti-polio antibody titre in newborn babies in post-polio eradication period in Nigeria.
Ughasoro MD; Nnakenyi I; Echendu N; Akpeh JO; Oji-Onuoha S; Anyaoha U; Mbanefo N; Ofodile K
Vaccine; 2023 Nov; 41(46):6820-6823. PubMed ID: 37806806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]